Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2007
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Immunity Pharma (IPL) develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. IPL's drugs are peptides with biologic activity. The peptides stimulate therapeutic cell-signaling processes that are often down-regulated in neurodegenerative diseases. The drugs mitigate disease progression by inducing survival-supporting processes, including reduction of inflammation and reduction of programed cell death (apoptosis). The lead drug, IPL344, is currently entering an open-label, phase-1/2a clinical trial with ALS patients. IPL344 originates from the research laboratory of Professor Irun Cohen at the Weizmann Institute of Science, Israel.
Q&A
- What is Immunity Pharma's primary focus in drug development?
- Immunity Pharma primarily focuses on developing therapies for neurodegenerative diseases, with an initial emphasis on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
- What type of drugs does Immunity Pharma develop?
- Immunity Pharma develops peptide-based drugs with biologic activity that stimulate therapeutic cell-signaling processes.
- What is the current clinical trial status of Immunity Pharma's lead drug, IPL344?
- Immunity Pharma's lead drug, IPL344, is currently entering an open-label, phase-1/2a clinical trial with ALS patients.
- Where did the research for IPL344 originate?
- IPL344 originated from the research laboratory of Professor Irun Cohen at the Weizmann Institute of Science in Israel.
- How many employees does Immunity Pharma have?
- Immunity Pharma has 1-10 employees.
- When was Immunity Pharma founded?
- Immunity Pharma was founded in March 2007.
- What is Immunity Pharma's current funding stage?
- Immunity Pharma is currently in the Pre-Funding stage.
- Who is the CEO of Immunity Pharma?
- Eran Ovadia is the CEO of Immunity Pharma.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
treatmentsdegenerative-diseasespharmaceuticalsamyotrophic-lateral-sclerosis-alsinflammatory-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | immunitypharma.com |
|---|
Identifiers & details
| Founded | 2007-3 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | immunitypharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|